RNA therapeutics represent a promising frontier in cancer research, offering targeted treatment options with potential for fewer side effects. These therapies utilize various RNA molecules, including messenger RNA (mRNA), small interfering RNA (siRNA), and microRNA (miRNA), to regulate gene expression or directly target cancer cells. mRNA vaccines, like those developed for COVID-19, stimulate the immune system to recognize and attack cancer-specific antigens. siRNA molecules can silence oncogenes or block proteins essential for tumor growth. Additionally, miRNAs regulate gene expression and control cellular processes implicated in cancer progression. By harnessing the power of RNA, researchers aim to develop precise, personalized treatments that disrupt cancer pathways while sparing healthy tissues. As this field advances, RNA therapeutics hold immense potential to revolutionize cancer care, offering hope for more effective and tailored treatment strategies.



Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States
Title : Graphene quantum dots: A new frontier for photodynamic therapy
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil